Markus Haeberlein
About Markus Haeberlein
Markus Haeberlein is the Senior Vice President and Head of Research at Alkermes, with extensive experience in computational and medicinal chemistry, and leadership roles in multiple biopharmaceutical companies.
Current Position at Alkermes
Markus Haeberlein currently serves as the Senior Vice President, Head of Research at Alkermes. He joined the company in December 2015 and oversees research initiatives in both Neuroscience and Oncology. His role involves a strong focus on project generation and candidate nomination.
Former Roles at Proteostasis Therapeutics
Before joining Alkermes, Markus Haeberlein was Senior Vice President and Chief Scientific Officer at Proteostasis Therapeutics, Inc. He held this position from 2012 to 2015, based in Cambridge, MA. During his tenure, he played a key role in the company's scientific leadership.
Career at AstraZeneca
Markus Haeberlein worked at AstraZeneca for 14 years from 1998 to 2012. He served as Executive Director and Lead of the AstraZeneca Global Chemistry Network, as well as Head of Medicinal Chemistry. His work was based in Södertälje, Sweden, where he contributed significantly to global chemistry initiatives.
Early Career and Other Roles
Markus Haeberlein began his career as a Computational Chemist at Astra Arcus from 1997 to 1998 in Södertälje, Sweden. He also worked as a Consulting professional at EcoBalance AB in Stockholm from 1996 to 1997.
Education and Academic Background
Markus Haeberlein earned his PhD in Physical Chemistry/Computational Chemistry from KTH Royal Institute of Technology, where he studied from 1992 to 1996. Prior to that, he completed an MSc in Physical Chemistry/Biochemistry/Organic Chemistry at the same institution, studying from 1987 to 1992.